Happy Holidays from the Sickle Cell Fund!

INDIVIDUALS LIVING WITH SCD IN THE U.S.

HOSPITALIZATIONS ANNUALLY DUE TO SCD IN THE U.S.

NEW DRUGS APPROVED BY FDA SINCE 2017

NEW DRUGS CURRENTLY IN PHASE III CLINICAL TRIALS